Differential Induction of Apoptosis by Antidepressants in Glioma and Neuroblastoma Cell Lines: Evidence for p-c-Jun, Cytochrome c, and Caspase-3 Involvement
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555 · cited 1×
“…of stressful stimuli is the c-Jun-N-terminal kinase (JNK) pathway, also known as the stressactivated protein kinase pathway (Kyriakis et al., 1994; Dérijard et al., 1995). c-Jun-N-terminal kinase (JNK) activation by phosphorylation has been shown to be important for neuronal cell death after…”
BackgroundBossy‐Wetzel, E., Newmeyer, D. D., & Green, D. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.37 · Cited by 1,225 · cited 1×
“Among the 11 known members of the caspase family of proteases, caspase-3 has been shown to be a major component involved in apoptosis (Bossy-Wetzel et al., 1998; Brustugun et al., 1998).”
BackgroundA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675 · cited 2×
“neurotrophic factor withdrawal in vitro and after injury in vivo (Xia et al., 1995; Dickens et al., 1997).”
BackgroundAzmitia, E. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00614-1 · Cited by 497
Neurotrophic effects of antidepressant drugs
CASTREN, E. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.004 · Cited by 244
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176 · cited 3×
“Several studies, mainly in vivo, point to neuroprotection and facilitation of neural cell survival via activation in the brain of neurotrophic factors, such as brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF) (Mercier et al., 2004).”
Background
Cited by
Sleire, L., Førde, H. E., Netland, I. A., Leiss, L., Skeie, B. S., & Enger, P. Ø. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.013 · Cited by 329
“apoptosis for glioma and neuroblastoma cells (145).”
McConnell, E. R., McClain, M. A., Ross, J., LeFew, W. R., & Shafer, T. J. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.05.001 · Cited by 167
“Cytotoxicity has been reported in glioma and human neuroblastoma cells following a 24 hr exposure to fluoxetine at similar concentrations (Levkovitz et al., 2005).”
BackgroundThe role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
Hodge, J. M., Wang, Y., Berk, M., Collier, F. M., Fernandes, T. J., Constable, M. J., Pasco, J. A., Dodd, S., Nicholson, G. C., Kennedy, R. L., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.003 · Cited by 122
Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
Metadata
- Authors
- Levkovitz, Y., Gil-Ad, I., Zeldich, E., Dayag, M., & Weizman, A.
- Venue
- Journal of Molecular Neuroscience
- Published
- 2005
- Volume
- 27
- Issue
- 1
- Pages
- 029-042
- ISSN
- 0895-8696 (ISSN-L)
- OpenAlex
- W2050486415
- Cited by
- 171
- References
- 6
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.